Disseminated intravascular coagulation risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Overview
Common risk factors in the development of DIC include trauma, sepsis, obstetric complications, cancers, and immunologic reactions
Risk Factors
Risk Factors
Common risk factors in the development of DIC include:[1][2].[3][4][5]
- Trauma
- Sepsis
- Obstetric complications
- Cancers
- Immunologic reactions
References
References
- ↑ Levi M, Ten Cate H (August 1999). “Disseminated intravascular coagulation”. N. Engl. J. Med. 341 (8): 586–92. doi:10.1056/NEJM199908193410807. PMID 10451465.
- ↑ Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G (September 2001). “Disseminated intravascular coagulation in solid tumors: clinical and pathologic study”. Thromb. Haemost. 86 (3): 828–33. PMID 11583315.
- ↑ Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G (May 2013). “Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study”. Chest. 143 (5): 1235–1242. doi:10.1378/chest.12-2112. PMID 23139140.
- ↑ Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, Casey W (November 1997). “Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans”. Lancet. 350 (9091): 1590–3. PMID 9393338.
- ↑ Gando S, Nanzaki S, Kemmotsu O (January 1999). “Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis”. Ann. Surg. 229 (1): 121–7. PMC 1191617. PMID 9923809.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
